Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
The purpose of this study was development of diclofenac sodium extended release compressed matrix pellets and optimization using Generalized Regression Neural Network (GRNN). According to Central Composite Design (CCD), ten formulations of diclofenac sodium matrix tablets were prepared. Extended release of diclofenac sodium was accomplished using Carbopol 71G as matrix substance. The process of direct pelletisation and subsequently compression of the pellets into MUPS tablets was applied in order to investigate a different approach in formulation of matrix systems and to achieve more control of the process factors over the principal response--the release of the drug. The investigated factors were X1-the percentage of polymer Carbopol 71 G and X2-crushing strength of the MUPS tablet. In vitro dissolution time profiles at 5 different sampling times were chosen as responses. Results of drug release studies indicate that drug release rates vary between different formulations, with a range of 1 hour to 8 hours of dissolution. The most important impact on the drug release has factor X1the percentage of polymer Carbopol 71 G. The purpose of the applied GRNN was to model the effects of these two causal factors on the in vitro release profile of the diclofenac sodium from compressed matrix pellets. The aim of the study was to optimize drug release in manner which enables following in vitro release of diclofenac sodium during 8 hours in phosphate buffer: 1 h: 15-40%, 2 h: 25-60%, 4 h: 35-75%, 8 h: >70%.
Ivic
Branka
B
Galenika a.d., R&D Institute, Batajnicki drum bb 11080 Belgrade, Serbia. ivicbranka@ikomline.net
Ibric
Svetlana
S
Betz
Gabriele
G
Zorica
Djuric
D
D000179:Acrylates; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D004008:Diclofenac / Q000008:administration & dosage / Q000737:chemistry; D004339:Drug Compounding; D016503:Drug Delivery Systems; D015195:Drug Design; D005079:Excipients; D006244:Hardness; D006813:Humidity; D007700:Kinetics; D008855:Microscopy, Electron, Scanning; D016571:Neural Networks, Computer; D010316:Particle Size; D012044:Regression Analysis; D012995:Solubility; D013607:Tablets
D000179:Acrylates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005079:Excipients; D013607:Tablets; C492578:carbopol 71G; D004008:Diclofenac